Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies

The use of clarithromycin in the setting of acute exacerbations of chronic obstructive pulmonary disease or community acquired pneumonia may be associated with increased cardiovascular events. These findings require confirmation in other datasets.